Destiny Wealth Partners’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1
Closed -$31 232
2022
Q4
$31 Sell
1
-3,522
-100% -$150K ﹤0.01% 674
2022
Q3
$137K Buy
+3,523
New +$150K 0.03% 205

Other funds holding BME

Destiny Wealth Partners's BME Position: Q1 2023 in Review

Destiny Wealth Partners sold out of BlackRock Health Sciences Trust (BME) in Q1 2023, closing a stake of 1 share — an estimated $31 sold.

Destiny Wealth Partners first reported a position in BME in Q3 2022 and held it in 2 quarters. The position peaked at $137K in Q3 2022. 71 funds tracked by Wall St. Rank hold BME as of Q1 2023.

  • Destiny Wealth Partners reported no remaining BlackRock Health Sciences Trust position as of Q1 2023 after selling out during the quarter.
  • Destiny Wealth Partners sold 1 BlackRock Health Sciences Trust share in Q1 2023, an estimated $31.
  • Destiny Wealth Partners first reported a position in BlackRock Health Sciences Trust in Q3 2022 and held it in 2 quarters.
  • Destiny Wealth Partners's BlackRock Health Sciences Trust position peaked at $137K in Q3 2022.
  • 71 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q1 2023.

Based on Destiny Wealth Partners's 13F filing for Q1 2023, filed 26 Apr 2023.